New Therapeutic Product for Bone Lesions – cmRNAbone Questionnaire for Clinicians
The final goal of the cmRNAbone is to provide patients and clinicians with a new therapeutic product to treat traumatic and osteoporotic bone lesions.
To treat specific lesions, this product would be customised using 3D bioprinting. With this questionnaire we want to better understand what final format/s of this product would be easily manageable and which one/s would be preferred by surgeons.
Please fill in the questionnaire by November 6, 2022. Thank you very much for your contribution!